The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 29.7

U.S. Childhood Cancer Survivors at January 1, 2017
Number of People Previously Diagnosed with Cancer as Children (Ages 0-19 Years) in the United States and Alive January 1, 2017
By International Classification of Childhood Cancer (ICCC)a Selected Group and Subgroup, Age Group, and Sex

Site Sex Complete Prevalence Counts by Age at Prevalence All Ages
Ages
0-19		 Ages
20-29		 Ages
30-39		 Ages
40-49		 Ages
50-59		 Ages
60+		 All Ages Diagnosed
between
1992-2017		 Diagnosed
before 1992
Count Percentb
All Sites Both 123,692 107,390 85,042 69,365 48,261 31,419 465,169 276,887 188,282 40
Male 66,400 56,217 37,588 24,260 17,772 14,039 216,276 145,845 70,431 33
Femalec 57,292 51,173 47,454 45,105 30,489 17,380 248,893 131,042 117,851 47
I Leukemia Both 41,504 26,765 12,980 8,095 3,949 904 94,197 73,161 21,036 22
Male 22,919 14,737 6,674 3,796 1,772 381 50,279 40,564 9,715 19
Female 18,585 12,028 6,306 4,299 2,177 523 43,918 32,597 11,321 26
Acute lymphocytic leukemiad Both 34,736 22,267 13,836 9,181 3,235 163 83,418 59,888 23,530 28
Male 19,110 12,368 7,144 4,842 1,623 92 45,179 33,327 11,852 26
Female 15,626 9,899 6,692 4,339 1,612 71 38,239 26,561 11,678 31
I(b) Acute myeloid leukemia Both 4,760 3,384 2,165 1,879 1,320 813 14,321 9,312 5,009 35
Male 2,522 1,722 1,056 829 646 405 7,180 4,855 2,325 32
Female 2,238 1,662 1,109 1,050 674 408 7,141 4,457 2,684 38
II(a) Hodgkin lymphoma Both 4,452 10,002 7,967 7,570 6,704 3,530 40,225 22,925 17,300 43
Male 2,634 5,441 3,727 3,661 3,321 1,759 20,543 11,861 8,682 42
Female 1,818 4,561 4,240 3,909 3,383 1,771 19,682 11,064 8,618 44
II(b,c,e) Non-Hodgkin lymphoma Both 7,540 7,947 5,314 2,971 2,311 2,098 28,181 19,769 8,412 30
Male 5,086 5,339 3,287 1,514 1,140 1,172 17,538 13,188 4,350 25
Female 2,454 2,608 2,027 1,457 1,171 926 10,643 6,581 4,062 38
III CNS and misc intracranial & intraspinal neoplasms Both 20,589 15,994 12,798 8,992 6,886 3,713 68,972 41,939 27,033 39
Male 10,962 8,505 6,310 4,284 2,997 1,697 34,755 22,351 12,404 36
Female 9,627 7,489 6,488 4,708 3,889 2,016 34,217 19,588 14,629 43
IV Neuroblastoma & other peripheral nervous cell tumor Both 9,451 3,682 2,589 2,552 2,149 1,530 21,953 12,839 9,114 42
Male 4,759 1,887 961 937 642 399 9,585 6,528 3,057 32
Female 4,692 1,795 1,628 1,615 1,507 1,131 12,368 6,311 6,057 49
VI Renal tumors Both 7,838 4,891 7,629 7,160 4,220 2,187 33,925 12,414 21,511 63
Male 3,578 2,179 4,379 3,969 2,351 1,259 17,715 5,569 12,146 69
Female 4,260 2,712 3,250 3,191 1,869 928 16,210 6,845 9,365 58
VIII Malignant bone tumors Both 4,136 4,555 3,763 3,841 3,498 2,066 21,859 11,808 10,051 46
Male 2,368 2,677 2,127 1,880 1,729 1,051 11,832 6,951 4,881 41
Female 1,768 1,878 1,636 1,961 1,769 1,015 10,027 4,857 5,170 52
VIII(a) Osteosarcoma Both 2,227 2,549 2,056 1,894 1,760 1,326 11,812 6,551 5,261 45
Male 1,174 1,412 1,171 878 853 683 6,171 3,648 2,523 41
Female 1,053 1,137 885 1,016 907 643 5,641 2,903 2,738 49
VIII(c) Ewing tumor & related sarcomas of bone Both 1,503 1,403 1,002 832 807 446 5,993 3,737 2,256 38
Male 934 887 591 405 365 162 3,344 2,329 1,015 30
Female 569 516 411 427 442 284 2,649 1,408 1,241 47
IX Soft tissue & other extraosseous sarcomas Both 7,334 6,827 5,494 4,607 5,918 9,330 39,510 17,509 22,001 56
Male 4,198 3,625 2,558 1,968 3,276 5,957 21,582 9,487 12,095 56
Female 3,136 3,202 2,936 2,639 2,642 3,373 17,928 8,022 9,906 55
X Germ cell & trophoblastic tumors & neoplasms of gonads Both 5,617 9,291 7,838 7,168 7,815 10,989 48,718 21,859 26,859 55
Male 3,029 6,025 4,653 4,095 4,346 5,289 27,437 13,619 13,818 50
Female 2,588 3,266 3,185 3,073 3,469 5,700 21,281 8,240 13,041 61

Footnotes:

a International Classification of Childhood Cancer is based on ICD-O-3. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, Third Edition. Cancer. April 1, 2005: Vol 103, No. 7 , pg 1457-1467.

b Percent diagnosed before 1992 of all ages complete prevalence counts.

c All sites females excludes breast cancer.

d SEER site recode Acute Lymphocytic Leukemia was used instead of the ICCC classification lymphocytic leukemia (Ia) because of statistical modeling requirements. For more information regarding the modeling of the prevalence estimates, see Mariotto et al. Long-Term Survivors of Childhood Cancers in the United States. Cancer Epidemiol Biomarkers Prev 2009, page 1034.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.